Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCel Ai Regulatory News (CLAI)

  • There is currently no data for CLAI

Changes in Board Composition - Grant of Warrants

17 Feb 2025 07:00

RNS Number : 2605X
Cel AI PLC
17 February 2025
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

17 February 2025

 

Cel AI PLC

 

("Cel AI" or "the Company")

 

Changes in Board Composition

Grant of Warrants

 

Cel AI (LSE: CLAI), a UK-based company that uses artificial intelligence (AI) to deliver the future of personalised beauty with tailored beauty advice and product recommendations, announces that Michael Edwards has resigned as Executive Chairman with immediate effect.

 

The Board would like to take this opportunity to thank Mr. Edwards for his contribution to the Company and wish them well for the future.

 

Furthermore, the Company is pleased to announce that Olivia Edwards has been appointed as Executive Chairperson. The appointment will take effect immediately.

 

Olivia Edwards brings 5 years of operational expertise to Cel AI's board, including corporate secretary duties and facilitating strategic financing across industries such as web3, gaming, AI and carbon capture. She has navigated reporting requirements in both Canada and the UK, helping guide companies through the public listing process and securing key investment. Olivia currently serves as a director of a Capital Pool Company (CPC) in Canada, bringing extensive experience with the regulatory landscape for public entities. She holds a Master of Management and has completed the Canadian Securities Course, strengthening her financial background.

 

Current directorships and/or partnerships:  

Former directorships and/or partnerships (within the last five years):  

- Kua Investments Inc (Toronto Stock Exchange listed company)

- Pioneer Media Holdings Inc (NEO Exchange listed company)

 

- Challenger X Plc (Aquis Stock Exchange listed company)

 

Were UKLR 6.4.8 to apply to the Company, there would be no further information to disclose.

Issue of Warrants

 

The Company also announces that it has granted a total of 23,000,000 warrants to subscribe for new ordinary shares of £0.001 each ("Warrants") to certain service providers and directors. The Warrants are exercisable at £0.0025 per ordinary share.

 

One third of the warrants will vest on 15 February 2025 with the remaining two thirds vesting in 24 equal monthly instalments thereafter. The Warrants have an exercise period of 5 years from the date of grant.

 

Following the issue of the Warrants, the Company has a total of 60,460,000 warrants in issue. 

 

The directors of the Company have been granted, in aggregate, 18,000,000 Warrants as set out below.

 

Director

Number of Warrants being issued

Total number of Warrants held including this issue

Olivia Edwards

10,000,000

10,000,000

Dark Peak Services Ltd

(company controlled by Nick Lyth)

5,000,000

5,000,000

Fidelio Partners Pte Ltd (company controlled by Mathew Lodge)

2,000,000

7,000,000

Misha Sher

1,000,000

3,000,000

 

For further information please contact:

 

Cel AI

 

Director

Olivia Edwards

 

via FSCF

First Sentinel Corporate Finance (FSCF)

 

Corporate Broker

Brian Stockbridge

 

+44 7858 888 007

 

About Cel AI PLC:

 

Cel AI offers an AI-driven skincare analysis tool that provides customers with personalised skincare recommendations based on their individual skin type and concerns. The tool utilises AI algorithms to analyse customer-provided information and offer tailored product recommendations from a range of skincare brands. Additionally, it develops and markets premium quality skincare and wellness products based on proprietary formulations incorporating lab-made cannabinoids. The Company is incorporated in the UK and listed on the Main Market of the London Stock Exchange. For more information, visit www.getcel.ai.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Olivia Edwards

2.

Reason for the Notification

a)

Position/status

Director

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cel AI plc

b)

LEI

213800IXPX4Z2MKX2U28

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of £0.001 each

Identification Code

GB00BK964W87

b)

Nature of the transaction

Grant of warrants at nil consideration over ordinary shares (exercise price of £0.0025)

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.0025

10,000,000

Ordinary Shares

d)

Aggregated information:

· Aggregated volume

· Price

As per 4. c)

e)

Date of the transaction

15 February 2025

f)

Place of the Transaction

Off Market

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dark Peak Services Ltd (company controlled by Nicholas Lyth)

2.

Reason for the Notification

a)

Position/status

Director

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cel AI plc

b)

LEI

213800IXPX4Z2MKX2U28

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of £0.001 each

Identification Code

GB00BK964W87

b)

Nature of the transaction

Grant of warrants at nil consideration over ordinary shares (exercise price of £0.0025)

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.0025

5,000,000

Ordinary Shares

d)

Aggregated information:

· Aggregated volume

· Price

As per 4. c)

e)

Date of the transaction

15 February 2025

f)

Place of the Transaction

Off Market

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Fidelio Partners Pte Lte (company controlled by Mathew Lodge)

2.

Reason for the Notification

a)

Position/status

Director

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cel AI plc

b)

LEI

213800IXPX4Z2MKX2U28

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of £0.001 each

Identification Code

GB00BK964W87

b)

Nature of the transaction

Grant of warrants at nil consideration over ordinary shares (exercise price of £0.0025)

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.0025

2,000,000

Ordinary Shares

d)

Aggregated information:

· Aggregated volume

· Price

As Per 4. c)

 

e)

Date of the transaction

15 February 2025

f)

Place of the Transaction

Off Market

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Misha Sher

2.

Reason for the Notification

a)

Position/status

Director

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cel AI plc

b)

LEI

213800IXPX4Z2MKX2U28

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of £0.001 each

Identification Code

GB00BK964W87

b)

Nature of the transaction

Grant of warrants at nil consideration over ordinary shares (exercise price of £0.0025)

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.0025

1,000,000

Ordinary Shares

d)

Aggregated information:

· Aggregated volume

· Price

As per 4. c)

e)

Date of the transaction

15 February 2025

f)

Place of the Transaction

Off Market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPUBWPUPAUBQ
Date   Source Headline
3rd Sep 20257:00 amRNSExpansion of Digital Asset Treasury - Restoration
1st Sep 202511:23 amRNSUpdate on Trading
1st Sep 20257:00 amRNSFast-Track Admission to the AQSE Growth Market
20th Aug 20253:35 pmRNSResult of General Meeting
1st Aug 20257:00 amRNSIntention to float on the AQSE Growth Market
18th Jul 20256:17 pmRNSGrant of Warrants and PDMRs
18th Jul 20251:07 pmRNSCompletion of Fundraising and PDMR holdings
18th Jul 20257:00 amRNSResult of General Meeting
8th Jul 20257:00 amRNSBitcoin Treasury Holdings Enhanced
4th Jul 20257:00 amRNSStrategic Bitcoin Treasury Acquisition
3rd Jul 20257:00 amRNSCel AI Secures Dedicated Bittensor Subnet
2nd Jul 20254:58 pmRNSTR-1: Standard notification of major holdings
1st Jul 20255:11 pmRNSDirector's Dealing
30th Jun 20256:15 pmRNSDirector's Dealings
30th Jun 20257:00 amRNSResult of £10m Conditional Fundraising
27th Jun 20255:19 pmRNSProposed placing by way of ABB and notice of GM
27th Jun 20257:00 amRNSChanges in Board Composition
9th Jun 202510:48 amRNSTR-1: Standard notification of major holdings
2nd Jun 20257:00 amRNSSubscription to raise £250,000
30th May 20251:59 pmRNSInterim results
29th May 20255:51 pmRNSCancellation of Directors’ Subscription
27th May 202511:04 amRNSReplacement-Cel AI Completes Fundraise of £500,000
23rd May 20256:01 pmRNSCel AI Completes Fundraise of £500,000
25th Feb 20253:46 pmRNSResult of AGM
17th Feb 20257:00 amRNSChanges in Board Composition - Grant of Warrants
31st Jan 20259:26 amRNSNotice of AGM
30th Dec 20247:00 amRNSAnnual results
28th Jun 20247:00 amRNSChanges in board composition
14th Jun 20246:09 pmRNSChanges in Board Composition
28th May 20247:00 amRNSInterim results
30th Apr 20247:00 amRNSBoard change
18th Mar 20247:00 amRNSDirector’s Dealings
7th Mar 20243:24 pmRNSTR-1 Notification and Director’s Dealings
13th Feb 20244:30 pmRNSResults of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.